autoimmune diseases
Coverage of autoimmune diseases in the Nexus archive.
- STAT+: Eli Lilly to buy three small vaccine developers
Eli Lilly announced it will acquire three early- and mid-stage vaccine developers—Curevo, LimmaTech Biologics, and Vaccine Company—for up to nearly $4 billion. The acquisitions follow recent purchases in cancer, autoimmune diseases, and sleep disorders, leveraging Lilly's cash reserves from its successful GLP-1 business.
- Hard-to-detect mutations explain how common autoimmune diseases arise
Advanced DNA sequencing has provided new evidence supporting an old theory about autoimmune diseases, revealing rare mutations in B cells linked to autoimmune thyroid conditions. The study highlights how hard-to-detect genetic changes contribute to common autoimmune disorders.
- Woman with three deadly diseases has ‘remarkable’ recovery after cell therapy
A 47-year-old woman with three life-threatening autoimmune diseases achieved a near-normal life after cell therapy at University Hospital Erlangen, marking a world first. The treatment reset her malfunctioning immune system, ending years of ineffective treatments and daily medical interventions.
- One woman, three autoimmune diseases: CAR-T therapy vanquishes ultra-rare disease trio
A woman with three autoimmune diseases achieved remission after CAR-T therapy, remaining symptom-free and medication-free for 14 months. The treatment, reported in Nature, represents a breakthrough for ultra-rare disease combinations.